The Armenicum Information Page
NUMBER OF PATIENTS USING ARMENICUM FOR AIDS DOUBLES
YEREVAN (Noyan Tapan)—Nikolay Kolesnikov, a Russian receiving
test
clinical treatment for
AIDS in Armenia, feels much better, Lev Zohrabian, director of
the
Republican Center for AIDS
Control & Prevention, said in a Noyan Tapan interview.
The effect of the treatment is determined according to the
internationally accepted key parameters
indicating HIV concentration in blood. Among such parameters is,
for
example, the amount of
T-lymphocytes in blood (CD-4+ cells) reflecting the virus content
in
blood in inversely proportional
dependence. One of the laboratories involved in tests on the drug has
a
sophisticated technology to
obtain such an indication. The given indication with Kolesnikov
has
increased almost three-fold by
now.
The state of all 30 patients receiving Armenicum is estimated
according
to similar parameters. All of
those participating in the tests are citizens of Armenia, except
Kolesnikov.
"It can be said with certainty that Armenicum drastically improves
the
quality of life of people
suffering from AIDS. The thing is that the widely accepted treatment
for
AIDS by the standard
method of triple therapy means that a patient has to regularly
take
medicine all through his life. Such
preparations used for treatment are highly toxic and cause
addiction,
which is not the case with
Armenicum and this is confirmed by relevant protocols," Zohrabian
said.
Besides, Zohrabian went on to explain, the patient is not
"confined to
the drug" forever; after taking a
course of treatment he is free in his action and feels well for a
certain period of time. The next stage
of clinical tests will show how long this period is and whether
remission is possible.
Per factual data, no virus is identified in the blood of most
patients
who received a course of
treatment for AIDS with the aid of Armenicum.